Publicly available gene expression data [22] (www.oncomine.org) were analyzed for the expression and prognostic relevance of EGFR and AURORA-A expression. AURORA-A transcripts were expressed at significantly higher levels in SCCHN tumor samples as compared to normal control tissue (p = 0.002, Figure 1), and the median relative expression in surviving patients was lower as compared to patients dying from SCCHN (n.s.). Here, EGFR is linked to head and neck squamous cell carcinoma.